North America Blood Testing Market

North America Blood Testing Market Size

The blood testing market is growing steadily in the North American region and was valued at USD 20.83 billion in 2023. The market in North America is anticipated to register a CAGR of 2.32% from 2024 to 2032 and be worth from USD 20.83 billion in 2024 to USD 25.02 billion by 2032.

MARKET DRIVERS

YOY growth in the number of people suffering from chronic diseases in North American countries is one of the primary factors driving the blood testing market in the North American region. According to the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six in ten adults in the United States suffer from at least one chronic disease, such as cancer, heart disease, or diabetes. Chronic diseases are the primary reason for the death of many people in the United States. A blood test can help predict future risks in a person. Nearly half of the older people in the U.S. are prone to chronic diseases such as diabetes and heart disease. One in 3 people above 60 years of age suffers from type 1 and type 2 diabetes. These people need to regularly check glucose levels in their blood, which is done through blood tests that drive the market forward in this region.

YOY rise in the number of blood donations and blood donation campaigns are further boosting the blood testing market in the North American region. Nearly 5 percent of people in the U.S. have donated blood every year. Blood donation is a process that starts with a blood test. Most of the people who want to donate blood should know about the blood group that they are having. For this reason, blood tests play an important role. The people who need to donate blood must undergo many tests to ensure they are not suffering from chronic diseases.

A growing number of people suffering from infectious and seasonal diseases is also propelling the North American blood testing market. Due to the COVID-19 pandemic, most people are undergoing this blood test to detect the virus in their blood. This is the most preferred test during the pandemic, which drives the blood testing market in this region. During this pandemic, most people need platelets to cure diseases. These people also undergo a blood test to check their platelet levels. Other diseases, such as hemoglobin levels in women, also require this blood test. Most women suffer from deficient hemoglobin due to various issues. These people require frequent blood testing, which drives the market forward. In addition, the market participants are manufacturing a disposable blood testing device that helps prevent diseases from spreading from patients to healthcare providers, which drives the market forward.

MARKET RESTRAINTS

However, the shortage of blood test material is anticipated to hamper this region's blood testing market growth. Blood tests need trained professionals, which otherwise leads to a severe blood infection, another primary factor restraining the market growth. Additionally, blood testing is a painful process that may hamper market growth. The lack of correct instruments for the blood test also restrained the market growth.

REGIONAL ANALYSIS

The North American region had the most significant share of the global market in 2023. More than 7 billion blood tests are performed in the U.S. each year. This is increased due to increasing awareness among people about keeping their bodies healthy. This blood test will help to track the overall body condition. In addition, the increased blood and platelets needed for patients every 60 seconds in the U.S. boost the market. Due to the increasing number of Alzheimer's cases in the United States, the researcher found an advance in technologies that early signs of Alzheimer's disease can be detected by using a simple blood test.

Different types of technology are used on the blood, which is taken for blood tests by scientists at the Public Health Agency of Canada's National Microbiology Laboratory (NML), for finding various blood-borne and sexually transmitted infections in the body. Considering all these factors, the market has a large share in this region.

KEY MARKET PLAYERS

A  few of the companies that are playing a notable role in the North American blood testing market profiled in the report are Bio-Rad Laboratories Inc. (U.S.), Siemens Healthcare (Germany), Grifols (Spain), Nanosphere Inc. (U.S.), BioMérieux (France), Dickinson and Company (U.S.), Ortho Clinical Diagnostics Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.) and Beckman Coulter (U.S.).

MARKET SEGMENTATION

This research report on the North American blood testing market is segmented and sub-segmented into the following categories.

By Type

• Complete Blood Count
• Blood Chemistry Tests
• Blood Enzymes Tests
• Blood Clotting Tests

By Disease 

• Anemia
• Infection
• Leukemia
• Hypokalemia
• Kidney Disorders
• Heart Attack
• Coronary Heart Disease

By Method

• Manual Blood Culture Testing
• Automated Blood Culture Testing

By Region

• The United States
• Canada
• Rest of North America